Investigations
1st investigations to order
reverse transcriptase-polymerase chain reaction (RT-PCR)
Test
Should be ordered in all patients with suspected RVF infection.[12] Live virus or nucleic acids may be detected in blood during the early phase of illness, or in postmortem tissue.
RT-PCR may not be readily available in all clinic and laboratory facilities in Rift Valley fever virus (RVFV)-endemic areas. Sample testing can be coordinated with specialised laboratories, such as the Centers for Disease Control and Prevention (CDC) in the US.
Result
positive for RVFV RNA
serum IgM or IgG detection with ELISA
Test
Typically, IgM can be detected during early stages of acute illness, shortly after the initial onset of symptoms (approximately 5 days after illness onset). IgG can typically be detected (approximately 7-10 days after illness onset) as a measure of previous exposure and persists for life; therefore it may not be representative of the causative agent for current febrile illness. Genus-specific cross-reactivity is common with ELISAs.[12]
Timepoints for IgM and IgG are dependent on the infection and human immune response, and can vary by patient. Approximate onset has been generalised comparatively with other mosquito-borne viruses that are endemic in overlapping regions.
ELISA assays may not be readily available in all clinic and laboratory facilities in RVFV-endemic areas. Sample testing can be coordinated with specialised laboratories, such as the CDC in the US.
Result
positive for anti-RVFV IgM or IgG antibodies
FBC
Test
High leukocyte count may be associated with higher mortality risk.[41]
Result
leukocyte count indicative of acute illness
serum electrolytes
Investigations to consider
coagulation studies
serum creatinine and urea
creatine phosphokinase (CPK)
Test
CPK levels more than twice the upper limit of the normal range may indicate systematic muscular stress.[55]
Result
may be elevated
Use of this content is subject to our disclaimer